Abstract: An insulating structure is provided for which comprises:(1) insulating material comprising one or more high-density, thermal/acoustical layers of highly bonded fibers; and(2) a chemically resistant, impermeable envelope enclosing said insulating material.Preferably, the insulating material also comprises one or more acoustical layers of loosely woven fiber cloth having openings correlated to the wavelength of the sound to be attenuated.Preferably the insulating structures of the subject invention comprise sealed mounting flanges extending from the edges of the envelope and means for removably attaching the insulation to the surface to be insulated.
Abstract: 7-Aminoazolo[1,5-a]pyrimidines of the formula ##STR1## where R.sup.1 is alkyl or aralkyl,R.sup.2 and R.sup.3 are each hydrogen or alkyl, andA is nitrogen or CR.sup.4, whereR.sup.4 is hydrogen, alkyl or halogen, and fungicides containing these compounds.
Type:
Grant
Filed:
October 19, 1984
Date of Patent:
October 14, 1986
Assignee:
BASF Aktiengesellschaft
Inventors:
Karl Eicken, Hermann Graf, Walter Gramlich, Hubert Sauter, Costin Rentzea, Ernst-Heinrich Pommer, Eberhard Ammermann
Abstract: A compound of the formula: ##STR1## wherein R is a hydrogen atom or a lower alkoxy group, X and Y, being the same or different, are each a hydrogen atom, a halogen atom, a lower alkyl group, a lower alkoxy group, a carboxy(lower)alkoxy group or a lower alkoxycarbonyl(lower)alkoxy group and Z is a hydrogen atom or a halogen atom, which is useful as a herbicide.
Type:
Grant
Filed:
November 17, 1982
Date of Patent:
December 4, 1984
Assignee:
Sumitomo Chemical Company, Limited
Inventors:
Hiroyuki Konishi, Naganori Hino, Hiroshi Matsumoto, Ryo Yoshida
Abstract: A 1-(4-aminobenzyl)-2,3-dioxopiperazine derivative represented by the formula: ##STR1## and an acid addition salt thereof have excellent carcinostatic activity but a low toxicity. Therefore, said compounds are useful as medicines and also as intermediates.
Type:
Grant
Filed:
July 16, 1980
Date of Patent:
March 13, 1984
Assignee:
Toyama Chemical Co., Ltd.
Inventors:
Takako Hori, Chosaku Yoshida, Yasuo Kiba, Ryuko Takeno, Joji Nakano, Jun Nitta, Sumiko Kishimoto, Shohachi Murakami, Hisatsugu Tsuda, Isamu Saikawa
Abstract: Treatment of the antiallergic agent 3,4-dihydro-5-methyl-6-(2-methylpropyl)-4-oxothieno[2,3-d]pyrimidine-2-car boxylic acid with N-methyl-D-glucamine gives a salt with improved solubility. Solutions of this salt have pH values in a range acceptable for topical formulations. Additionally, solutions of the subject salt exhibit good stability which can be demonstrated by retention of potency. The salt is comprised of a 1:1 molecular ratio of the glucamine base to the acid.